These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 18004079

  • 1. Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma.
    Rikimaru T, Taketomi A, Yamashita Y, Shirabe K, Hamatsu T, Shimada M, Maehara Y.
    Oncology; 2007; 72(1-2):69-74. PubMed ID: 18004079
    [Abstract] [Full Text] [Related]

  • 2. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.
    Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Hara Y, Kobayashi S, Iwase H.
    Breast Cancer Res Treat; 2005 Nov; 94(1):11-6. PubMed ID: 16172792
    [Abstract] [Full Text] [Related]

  • 3. Role of histone deacetylase expression in intrahepatic cholangiocarcinoma.
    Morine Y, Shimada M, Iwahashi S, Utsunomiya T, Imura S, Ikemoto T, Mori H, Hanaoka J, Miyake H.
    Surgery; 2012 Mar; 151(3):412-9. PubMed ID: 21982637
    [Abstract] [Full Text] [Related]

  • 4. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma.
    Hsu YC, Fu HH, Jeng YM, Lee PH, Yang SD.
    J Clin Oncol; 2006 Aug 10; 24(23):3780-8. PubMed ID: 16754939
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T, Aishima S, Umeda K, Sanefuji K, Fujita N, Sugimachi K, Gion T, Taketomi A, Maehara Y, Tsuneyoshi M.
    J Surg Oncol; 2009 Dec 01; 100(7):575-9. PubMed ID: 19697358
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W, Röske A, Niesporek S, Noske A, Buckendahl AC, Dietel M, Gekeler V, Boehm M, Beckers T, Denkert C.
    Clin Cancer Res; 2008 Mar 15; 14(6):1669-77. PubMed ID: 18347167
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.
    Lee YC, Pan HW, Peng SY, Lai PL, Kuo WS, Ou YH, Hsu HC.
    Eur J Cancer; 2007 Mar 15; 43(4):736-44. PubMed ID: 17267202
    [Abstract] [Full Text] [Related]

  • 12. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection.
    Chau GY, Lui WY, Chi CW, Chau YP, Li AF, Kao HL, Wu CW.
    Eur J Surg Oncol; 2008 Mar 15; 34(3):333-8. PubMed ID: 17218078
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase 1 mRNA expression in lung cancer.
    Sasaki H, Moriyama S, Nakashima Y, Kobayashi Y, Kiriyama M, Fukai I, Yamakawa Y, Fujii Y.
    Lung Cancer; 2004 Nov 15; 46(2):171-8. PubMed ID: 15474665
    [Abstract] [Full Text] [Related]

  • 14. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
    Guo C, Liu QG, Yang W, Zhang ZL, Yao YM.
    Hepatobiliary Pancreat Dis Int; 2008 Oct 15; 7(5):490-6. PubMed ID: 18842495
    [Abstract] [Full Text] [Related]

  • 15. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
    Peng SY, Lai PL, Pan HW, Hsiao LP, Hsu HC.
    Oncol Rep; 2008 Apr 15; 19(4):1045-53. PubMed ID: 18357395
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
    Choi SB, Lee JG, Kim KS, Yoon DS, Choi JS, Lee WJ, Kim BR.
    Hepatogastroenterology; 2008 Apr 15; 55(88):2140-5. PubMed ID: 19260493
    [Abstract] [Full Text] [Related]

  • 20. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Matsubara T, Ono T, Yamanoi A, Tachibana M, Nagasue N.
    J Surg Oncol; 2007 Mar 01; 95(3):241-9. PubMed ID: 17323338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.